Harvard Bioscience (HBIO) Earnings Date & Reports

Harvard Bioscience Inc is a developer, manufacturer, and seller of technologies, products, and services that enable advances in life science applications, including research, drug and therapy discovery, bioproduction, and preclinical testing... Show more

Industry: #Biotechnology

Get AI intraday signals

A.I. Advisor

published Earnings

HBIO is expected to report earnings to rise 92.86% to -27 cents per share on November 10

Harvard Bioscience HBIO Stock Earnings Reports

Q3'26

Est.

$-0.27

Q2'26

Beat

by $0.24

Q1'26

Missed

by $0.33

Q4'25

Missed

by $0.10

Q3'25

Missed

by $0.04

The last earnings report on August 11 showed earnings per share of -14 cents, beating the estimate of -37 cents. With 5.89K shares outstanding, the current market capitalization sits at 34.10M.

View a ticker or compare two or three

HBIO

Daily Signal:

Gain/Loss:

Interact to see
Advertisement

A.I.Advisor

published price charts

Last 5 trading days